SpringWorks Therapeutics
SWTX
SWTX was delisted on the 30th of June, 2025.
3 hedge funds and large institutions have $2.16M invested in SpringWorks Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 218 closing their positions.
99% less funds holding
Funds holding: 223 → 3 (-220)
100% less capital invested
Capital invested by funds: $3.65B → $2.16M (-$3.65B)
100% less funds holding in top 10
Funds holding in top 10: 18 → 0 (-18)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 218
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
103% less ownership
Funds ownership: 103.05% → 0.05% (-103%)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$341M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$335M |
| 3 |
GCL
Glazer Capital LLC
New York
|
-$193M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$142M |
| 5 |
State Street
Boston,
Massachusetts
|
-$141M |
SWTX Hedge Fund Activity: Q3 2025 in Review
3 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2025, worth a combined $2.16M — down 100% from $3.65B a quarter earlier.
Sellers outnumbered buyers: 218 funds closed out of SWTX and 0 opened new positions — a net loss of 218 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $341M sold.
- 3 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2025, down from 223 in Q2 2025.
- Funds reported $2.16M of SpringWorks Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new SpringWorks Therapeutics positions in Q3 2025 and 218 closed out, a net change of -218 holders.
- The largest SpringWorks Therapeutics seller in Q3 2025 was BlackRock, an estimated $341M sold.
Based on aggregated 13F filings for Q3 2025.